Nomura Holdings’s Estrella Immunopharma ESLA Stock Holding History

Nomura Holdings’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-197,000	Closed	-$2.02M	–	1542
2022 Q4	$2.02M	Hold	197,000	–	–	0.01%	704
2022 Q3	$1.98M	Hold	197,000	–	–	0.01%	814
2022 Q2	$1.98M	Hold	197,000	–	–	0.01%	797
2022 Q1	$1.97M	Hold	197,000	–	–	0.01%	888
2021 Q4	$1.95M	Buy	+197,000	New	+$1.95M	﹤0.01%	1007

Other funds holding ESLA

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

SOA

Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Nomura Holdings's ESLA Position: Q1 2023 in Review

Nomura Holdings sold out of Estrella Immunopharma (ESLA) in Q1 2023, closing a stake of 197,000 shares — an estimated $2.02M sold.

Nomura Holdings first reported a position in ESLA in Q4 2021 and held it in 5 quarters. The position peaked at $2.02M in Q4 2022. 8 funds tracked by Wall St. Rank hold ESLA as of Q1 2023.

Nomura Holdings reported no remaining Estrella Immunopharma position as of Q1 2023 after selling out during the quarter.
Nomura Holdings sold 197,000 Estrella Immunopharma shares in Q1 2023, an estimated $2.02M.
Nomura Holdings first reported a position in Estrella Immunopharma in Q4 2021 and held it in 5 quarters.
Nomura Holdings's Estrella Immunopharma position peaked at $2.02M in Q4 2022.
8 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.